1.Advances on Golgi glycoprotein 73 and its association with diseases.
Journal of Zhejiang University. Medical sciences 2012;41(2):215-221
Golgi glycoprotein 73(GP73) is a transmembrane glycoprotein residing in the cis-Golgi complex, which is strongly expressed in hepatocellular carcinoma (HCC) and secreted into the blood. It has been regarded as a promising serum tumor marker for the detection of HCC with higher sensitivity and specificity than AFP. GP73 is also significantly elevated in kidney cancer, prostate cancer, lung adenocarcinoma, esophageal cancer and seminomas; therefore, it would be helpful for the diagnosis of these diseases. However, the function of GP73 and the regulatory mechanism for its expression are unclear. In this article, the physical-chemical properties, the regulation of its expression, the relation with various cancers and the clinical applications of GP73 are reviewed.
Biomarkers, Tumor
;
metabolism
;
Humans
;
Kidney
;
metabolism
;
Liver Diseases
;
metabolism
;
Membrane Proteins
;
chemistry
;
metabolism
;
physiology
;
Neoplasms
;
diagnosis
;
metabolism
2.Lymphoepithelial carcinoma of renal pelvis: report of a case.
Chinese Journal of Pathology 2010;39(11):772-773
Carcinoma, Squamous Cell
;
metabolism
;
pathology
;
surgery
;
Female
;
Follow-Up Studies
;
Humans
;
Keratin-7
;
metabolism
;
Keratins
;
metabolism
;
Kidney Neoplasms
;
metabolism
;
pathology
;
surgery
;
Kidney Pelvis
;
Middle Aged
;
Mucin-1
;
metabolism
3.Expression of beta-human chorionic gonadotropin genes in renal cell cancer and benign renal disease tissues.
Yongguang JIANG ; Fuqing ZENG ; Chuanguo XIAO ; Junmin LIU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2003;23(3):291-293
To study the expression of beta-human chorionic gonadotropin (beta hCG) genes in renal cell carcinomas (RCC) and benign renal disease tissues, nested reverse transcription-polymerase chain reaction (RT-PCR) and restriction endonuclease analysis were employed to detect the expression of beta hCG genes in 44 cases of RCC tissues and 24 cases of benign renal disease tissues. It was found that 52% RCC samples revealed positive for beta hCG mRNA expression. Positive rate in advanced stage and poorly differentiated RCC was higher, but there was no significant difference. The positive rate of beta hCG mRNA expression was 54% in 24 cases of benign renal tissues, including 3 cases out of 6 polycystic kidneys, 7 cases out of 13 renal atrophies, 2 cases out of 2 oncocytomas and 1 case out of 2 pyonephrotic kidneys. beta 7 was most frequently transcribed subtype gene independent on the histology. These findings suggested beta hCG gene transcription is not only involved in RCC but also in benign renal diseases.
Adult
;
Biomarkers, Tumor
;
Carcinoma, Renal Cell
;
genetics
;
metabolism
;
Chorionic Gonadotropin, beta Subunit, Human
;
biosynthesis
;
genetics
;
Humans
;
Kidney
;
metabolism
;
Kidney Diseases
;
genetics
;
metabolism
;
Kidney Neoplasms
;
genetics
;
metabolism
;
Polycystic Kidney Diseases
;
metabolism
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Reverse Transcriptase Polymerase Chain Reaction
4.Clear cell sarcoma of the kidney: a case report.
Joong Seok SEO ; Yong Wook PARK ; Kye Yong SONG ; Seon Taek CHANG
Journal of Korean Medical Science 1989;4(3):149-153
Clear cell sarcoma of the kidney (CCSK) is a highly malignant childhood tumor, distinguished from classic Wilms' tumor by its propensity to metastasize to the skeletal system. Authors described a case of CCSK from a 3-year-old boy in the right kidney, showing various histologic features, such as classic, epithelioid, trabecular, neurilemmoma-like, cystic and entrapped collecting tubular pattern. Ultrastructurally epithelial differentiation was absent. Immunohistochemically, none of the intrinsic tumor cells showed positive staining with the antibodies against the keratin, S-100 protein, carcinoembryonic antigen, vimentin, desmin and myoglobin, suggesting primitive mesenchymal cell in origin.
Child, Preschool
;
Humans
;
Immunohistochemistry
;
Kidney Neoplasms/metabolism/*pathology
;
Male
;
Neoplasm Metastasis
;
Sarcoma/metabolism/*pathology
5.Multiple effects of vitamin D.
Chinese Medical Journal 2013;126(15):2978-2983
6.Imaging manifestations of renal primary neuroectodermal tumors.
Xi-Wen NAN ; Guang-Jian TANG ; Jian-Guo XU ; Tai-Song PENG ; Lai-Sheng MIAO ; Zhi-Gao XU ; Cong BAI ; Ping YU ; Yong-Li GAO ; Bao-Tang HAO
Chinese Medical Journal 2012;125(19):3595-3597
7.Renal papillary adenoma in transplant donor kidney: report of a case.
Xue-juan BAI ; Min YANG ; Qi YU ; Ning LI
Chinese Journal of Pathology 2009;38(5):353-354
Adenoma
;
metabolism
;
pathology
;
surgery
;
Humans
;
Keratin-7
;
metabolism
;
Kidney Neoplasms
;
metabolism
;
pathology
;
surgery
;
Kidney Transplantation
;
Living Donors
;
Male
;
Mucin-1
;
metabolism
;
Young Adult
8.Progress of small ubiquitin-related modifiers in kidney diseases.
Ou LI ; Qian MA ; Fei LI ; Guang-Yan CAI ; Xiang-Mei CHEN ; Quan HONG
Chinese Medical Journal 2019;132(4):466-473
OBJECTIVE:
Small ubiquitin-related modifiers (SUMOs) are a group of post-translational modification proteins extensively expressed in eukaryotes. Abnormal SUMOylation can lead to the development of various diseases. This article summarizes the progress on research of the role of SUMOs in various types of kidney diseases to further increase the understanding of the regulatory functions of SUMOylation in the pathogenesis of kidney diseases.
DATA SOURCES:
This review was based on articles published in the PubMed databases up to January 2018, using the keywords including "SUMOs," "SUMOylation," and "kidney diseases."
STUDY SELECTION:
Original articles and critical reviews about SUMOs and kidney disease were selected for this review. A total of 50 studies were in English.
RESULTS:
SUMO participates in the activation of NF-κB inflammatory signaling pathway, playing a central regulatory role in the inflammation and progression of DN, and the secretion of various chemokines in AKI. SUMO involves in the regulation of TG2 and Nrf2 antioxidant stress, affecting renal tubular injury in AKI. SUMO affects the MAPK/ERK pathway, regulating intracellular signal transduction, modulating the transcription and expression of effector molecules in DN. SUMO contributes to the TGF-β/Smad pathway, leading to fibrosis of the kidney. The conjugate combination of SUMO and p53 regulates cell proliferation and apoptosis, and participates in the regulation of tumorigenesis. In addition, SUMOylation of MITF modulates renal tumors secondary to melanoma, Similarly, SUMOylation of tumor suppressor gene VHL regulates the occurrence of renal cell carcinoma in VHL syndrome.
CONCLUSIONS
Tissue injury, inflammatory responses, fibrosis, apoptosis, and tumor proliferation in kidney diseases all involve SUMOs. Further research of the substrate SUMOylation and regulatory mechanisms of SUMO in kidney diseases will improve and develop new treatment measures and strategies targeting kidney diseases.
Acute Kidney Injury
;
etiology
;
Carcinoma, Renal Cell
;
etiology
;
Diabetic Nephropathies
;
etiology
;
Fibrosis
;
Humans
;
Kidney
;
pathology
;
Kidney Diseases
;
etiology
;
metabolism
;
Kidney Neoplasms
;
etiology
;
SUMO-1 Protein
;
physiology
;
Sumoylation
9.Pathologic features of recently identified renal cell carcinoma.
Xiang FAN ; Qiu RAO ; Li-hua ZHANG
Chinese Journal of Pathology 2013;42(8):569-573
Adenocarcinoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Papillary
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Renal Cell
;
genetics
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Humans
;
Immunohistochemistry
;
Kidney Diseases, Cystic
;
genetics
;
metabolism
;
pathology
;
Kidney Neoplasms
;
genetics
;
metabolism
;
pathology
;
Thyroid Neoplasms
;
genetics
;
metabolism
;
pathology
;
Translocation, Genetic
10.Expression of TFAR19(PDCD5) in normal human kidney, renal clear cell carcinoma, normal human bladder and bladder carcinoma.
Lin XIONG ; Wan-long TAN ; Zhao-cun YU ; Yuan-dong WU ; He HUANG ; Guo-zhi ZHAO ; Wen-hui ZHU ; Shao-bin ZHENG
Journal of Southern Medical University 2006;26(6):805-809
OBJECTIVETo detect the expression of apoptosis gene PDCD5 in tissues of normal human kidney, renal clear cell carcinoma, normal bladder and bladder carcinoma, and explore the role of PDCD5 gene in renal clear cell carcinoma and bladder carcinoma.
METHODSIndirect immunohistochemistry was employed to detect PDCD5 expression in 63 kidney specimens and 42 bladder specimens. Positive expression rates and intensity of PDCD5 protein expression in the kidney tissue were investigated microscopically and by computerized image analysis. Positive expression rate in the bladder tissue was investigated by microscopic observation.
RESULTSThe results of immunohistochemical staining showed PDCD5 protein overexpression in the renal tubule of normal human kidney tissues and downregulation with the stage increase of renal clear cell carcinoma. PDCD5 protein expression showed statistical significance in tissues of normal kidney and renal clear cell carcinoma in all stages. No obvious PDCD5 expression was detected in the tissues of normal human bladder and bladder carcinoma.
CONCLUSIONPDCD5 is an important apoptosis-regulating factor in the occurrence of renal clear cell carcinoma, and its expression is extremely low in tissues of normal human bladder and bladder carcinoma.
Adult ; Aged ; Apoptosis Regulatory Proteins ; biosynthesis ; Carcinoma, Renal Cell ; metabolism ; Carcinoma, Transitional Cell ; metabolism ; Female ; Humans ; Immunohistochemistry ; Kidney ; metabolism ; Kidney Neoplasms ; metabolism ; Male ; Middle Aged ; Neoplasm Proteins ; biosynthesis ; Urinary Bladder ; metabolism ; Urinary Bladder Neoplasms ; metabolism